BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 10348738)

  • 1. Comparative genomics of BCG vaccines by whole-genome DNA microarray.
    Behr MA; Wilson MA; Gill WP; Salamon H; Schoolnik GK; Rane S; Small PM
    Science; 1999 May; 284(5419):1520-3. PubMed ID: 10348738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
    Mahairas GG; Sabo PJ; Hickey MJ; Singh DC; Stover CK
    J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a working seed lot of BCG and quality control by PCR genotyping.
    Trovero A; Argüelles C; Cataldi A
    Rev Argent Microbiol; 2010; 42(1):4-10. PubMed ID: 20461286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection.
    Sherman DR; Guinn KM; Hickey MJ; Mathur SK; Zakel KL; Smith S
    J Infect Dis; 2004 Jul; 190(1):123-6. PubMed ID: 15195251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
    Prygiel M; Janaszek-Seydlitz W; Bucholc B
    Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis.
    Philipp WJ; Nair S; Guglielmi G; Lagranderie M; Gicquel B; Cole ST
    Microbiology (Reading); 1996 Nov; 142 ( Pt 11)():3135-45. PubMed ID: 8969511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics of Mycobacterium bovis.
    Gordon SV; Eiglmeier K; Garnier T; Brosch R; Parkhill J; Barrell B; Cole ST; Hewinson RG
    Tuberculosis (Edinb); 2001; 81(1-2):157-63. PubMed ID: 11463237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.
    Ganguly N; Siddiqui I; Sharma P
    Tuberculosis (Edinb); 2008 Nov; 88(6):510-7. PubMed ID: 18640874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strains.
    Garcia Pelayo MC; Uplekar S; Keniry A; Mendoza Lopez P; Garnier T; Nunez Garcia J; Boschiroli L; Zhou X; Parkhill J; Smith N; Hewinson RG; Cole ST; Gordon SV
    Infect Immun; 2009 May; 77(5):2230-8. PubMed ID: 19289514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG Vaccines.
    Tran V; Liu J; Behr MA
    Microbiol Spectr; 2014 Feb; 2(1):MGM2-0028-2013. PubMed ID: 26082111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR identification of Mycobacterium bovis BCG.
    Talbot EA; Williams DL; Frothingham R
    J Clin Microbiol; 1997 Mar; 35(3):566-9. PubMed ID: 9041390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rv1773 is a transcriptional repressor deleted from BCG-Pasteur.
    Alexander DC; Behr MA
    Tuberculosis (Edinb); 2007 Sep; 87(5):421-5. PubMed ID: 17669688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains.
    Mattow J; Jungblut PR; Schaible UE; Mollenkopf HJ; Lamer S; Zimny-Arndt U; Hagens K; Müller EC; Kaufmann SH
    Electrophoresis; 2001 Aug; 22(14):2936-46. PubMed ID: 11565788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains.
    Seki M; Honda I; Fujita I; Yano I; Yamamoto S; Koyama A
    Vaccine; 2009 Mar; 27(11):1710-6. PubMed ID: 19200449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.
    Lewis KN; Liao R; Guinn KM; Hickey MJ; Smith S; Behr MA; Sherman DR
    J Infect Dis; 2003 Jan; 187(1):117-23. PubMed ID: 12508154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of strains in Mycobacterium tuberculosis complex by DNA sequence polymorphisms, including rapid identification of M. bovis BCG.
    Frothingham R
    J Clin Microbiol; 1995 Apr; 33(4):840-4. PubMed ID: 7790448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The genetic regulation of host response to inoculation with Mycobacterium bovis (BCG) and Mycobacterium tuberculosis H37RV].
    Nikonenko BV; Mezhlumova MB; Moroz AM
    Biull Eksp Biol Med; 1990 Nov; 110(11):526-8. PubMed ID: 2128037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.
    Liu J; Tran V; Leung AS; Alexander DC; Zhu B
    Hum Vaccin; 2009 Feb; 5(2):70-8. PubMed ID: 19164935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro evolution of BCG vaccines.
    Mostowy S; Tsolaki AG; Small PM; Behr MA
    Vaccine; 2003 Oct; 21(27-30):4270-4. PubMed ID: 14505909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.